Senate HELP Committee Hearing Highlights Urgent Need to Reform 340B Program — Lawmakers Push for Transparency and Patient ...
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
Katherine Denney, Alissa Fleming, Gregory Fliszar Ph.D. In the fall of 2024, several pharmaceutical companies reacted to HRSA's decision to prevent them from implementing a rebate model for their ...
An obscure, supposedly free federal program is blowing a hole in state budgets – by depriving state governments of billions in corporate tax revenue and inflating costs for their public employee ...
For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...
Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.
Five companies account for 76.1% of the 340B contract pharmacy market, according to Drug Channels. Since Congress established the 340B program in 1992, the program has expanded to include 32,069 ...
Diversity Health Center unveiled their brand-new community garden Monday, but it’s one of their biggest programs that could ...
A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results